Pure Global
PACTR201206000159453

The pharmacokinetics of lopinavir in South African HIV-infected volunteers receiving rifampicin with adjusted doses of LOPINAVIR/ritonavir.

UCT; UCT·Not Applicable·Pan Africa Clinical Trials Registry·otherRecruiting
Study focus
Disease/Condition
Infections and Infestations; Infections and Infestations
Intervention type
other
Sponsor & location
Primary sponsor
UCT; UCT
Funder
EDCDTP; EDCDTP
Location
South Africa
Timeline & enrollment
Phase
Not Applicable
Start date
Jan 01, 1900
End date
Jan 01, 1900
Summary

There is an urgent need to investigate practical approaches to using antiretrovirals together with tuberculosis (TB) treatment. We propose to study the pharmacokinetics of LPV in 24 HIV-infected adult volunteers established on an antiretroviral regimen comprising LPV/RTV plus 2 NRTIs at steady state and in combination with rifampicin.

ICD-10 classifications
Certain infectious and parasitic diseasesInfestation, unspecifiedOther specified infestationsOther infestationsSequelae of infectious and parasitic diseases
Data source
Registry
Pan Africa Clinical Trials Registry
Trial ID
PACTR201206000159453
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for PACTR201206000159453 through Pure Global AI's free database. This Not Applicable trial is sponsored by UCT; UCT and is currently Recruiting. The study focuses on Infections and Infestations; Infections and Infestations.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Pan Africa Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.